Processed EEG and patient outcome

Abstract

The era of research evaluating clinical outcomes associated with processed electroencephalogram (EEG) monitoring began with the first randomized trial of bispectral index monitoring (BIS) performed as part of the clearance process for approving routine clinical use of the BIS monitor by the United States Food and Drug Administration. Subsequent to this initial investigation, numerous other clinical investigations have demonstrated that the use of processed EEG monitors as an additional method of patient assessment and an aid to anaesthetic dosing can decrease anaesthetic usage and hasten recovery times. Because of the presumed association between anaesthetic effect and EEG changes, it is not surprising that the additional research has focused on the impact of processed EEG monitoring on postoperative outcomes and perioperative safety especially the prevention of intraoperative awareness.